Immuron
$1.84
24H
Market Cap
Volume
Supply
Price Chart
About Immuron - IMRN
Immuron Limited is an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut pathogen-mediated diseases. Their product portfolio includes Travelan and Protectyn, which are over-the-counter dietary supplements aimed at enhancing gut health and immune function.
What are Immuron's core values and mission statement?
Immuron Limited's mission is typically centered around its dedication to the development and commercialization of oral immunotherapies using its proprietary technology platform for the treatment of various diseases. Core values would generally include a commitment to innovation, scientific excellence, and improving patient health, although you should consult the company's official publications or website for their specific, current mission statement and core values.
Who founded Immuron and when?
Immuron Limited, an Australian biopharmaceutical company, was founded in 1994.
Who leads Immuron?
Immuron Limited is led by an Executive Management team, typically headed by a Chief Executive Officer. For the most current leadership, please refer to the company's official website or latest corporate filings.
Where is Immuron located, and what is its base country?
Immuron Limited is headquartered in Melbourne, Australia, which is also its base country.
On which exchanges is Immuron traded?
Immuron Limited is traded on the Australian Securities Exchange (ASX) under the ticker symbol IMC and on the NASDAQ Capital Market under the ticker symbol IMRN.
Historical data
Immuron (IMRN) Price Live Data
The live price of Immuron (IMRN) is $1.84, with a trading volume of 7,759 in the last 24 hours. Wrapstocks updates the IMRN price in real-time. Immuron is down -2.13% in the last 24 hours. The company has a live market cap of $10,990,099.00 and a supply of 5,972,880 IMRN stocks.
Immuron (IMRN) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 8 minutes.
